HomeSENORES • NSE
add
Senores Pharmaceuticals Ltd
Previous close
₹806.65
Day range
₹810.00 - ₹828.00
Year range
₹435.25 - ₹848.50
Market cap
37.76B INR
Avg Volume
297.68K
P/E ratio
40.68
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.62B | 60.75% |
Operating expense | 632.70M | 89.83% |
Net income | 323.80M | 152.18% |
Net profit margin | 20.02 | 56.90% |
Earnings per share | 6.54 | — |
EBITDA | 484.55M | 119.81% |
Effective tax rate | 25.87% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.03B | 1,354.69% |
Total assets | 12.88B | 89.97% |
Total liabilities | 4.54B | 26.37% |
Total equity | 8.34B | — |
Shares outstanding | 49.51M | — |
Price to book | 4.91 | — |
Return on assets | — | — |
Return on capital | 9.40% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 323.80M | 152.18% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
194
